Key result
Stent implantation shows no difference in in-hospital mortality versus CABG for left main disease.
Why the study?
Recent randomized controlled trials sparked debate regarding the optimal treatment of patients suffering from left main coronary artery disease.
Does stent implantation compared to CABG improve in-hospital outcomes in patients with chronic coronary syndrome and left main disease?
Observational (n=10,238)
Yes
Does stent implantation compared to CABG improve in-hospital outcomes in patients with chronic coronary syndrome and left main disease?
In a nationwide German registry of patients with chronic coronary syndrome and left main disease, stenting showed similar in-hospital mortality and stroke rates compared to CABG, but with lower risks of bleeding, delirium, and shorter hospital stays.
Answers are grounded in this paper and cite their sources.
Comparable in-hospital mortality supports equipoise for stenting; leaves open long-term outcomes versus CABG in left main disease.
BACKGROUND: Recent randomized controlled trials have sparked debate about the optimal treatment of patients suffering from left main coronary artery disease. The present study analyzes outcomes of left main stenting versus coronary bypass grafting (CABG) in a nationwide registry in patients with chronic coronary syndrome (CCS). METHODS: All cases suffering from CCS and left main coronary artery disease treated either with CABG or stent, were identified within the database of the German bureau of statistics. Logistic or linear regression models were used with 20 baseline patient characteristics as potential confounders to compare both regimens. RESULTS: In 2018, 1318 cases with left main stenosis were treated with CABG and 8,920 with stent. Patients assigned for stenting were older (72.58 ± 9.87 vs. 68.63 ± 9.40, p < 0.001) and at higher operative risk, as assessed by logistic EuroSCORE (8.77 ± 8.45 vs. 4.85 ± 4.65, p < 0.001). After risk adjustment, no marked differences in outcomes were found for in-hospital mortality and stroke (risk adjusted odds ratio (aOR) for stent instead of CABG: aOR mortality: 1.08 [95% CI 0.66; 1.78], p = 0.748; aOR stroke: 0.59 [0.27; 1.32], p = 0.199). Stent implantation was associated with a reduced risk of relevant bleeding (aOR 0.38 [0.24; 0.61], p < 0.001), reduced prolonged ventilation time (aOR 0.54 [0.37 0.79], p = 0.002), and postoperative delirium (aOR 0.16 [0.11; 0.22], p < 0.001). Furthermore, stent implantation was associated with shorter hospital stay (- 6.78 days [- 5.86; - 7.71], p < 0.001) and lower costs (- €10,035 [- €11,500; - €8570], p < 0.001). CONCLUSION: Left main stenting is a safe and effective treatment option for CCS-patients suffering from left main coronary artery disease at reasonable economic cost. Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany. All cases with chronic coronary syndrome and left main stenosis treated in 2018 in Germany either with left main stenting or coronary bypass grafting were extracted from a nation-wide database. In-hospital outcomes were compared after logistic regression analysis.
No takes yet. Share an insight, caveat, or question.
Stachon et al. (2021) conducted an observational in Chronic coronary syndrome and left main disease (n=10,238). Stent implantation vs. Coronary artery bypass grafting (CABG) was evaluated on In-hospital mortality (aOR 1.08, 95% CI 0.66; 1.78, p=0.748). Stent implantation showed no significant difference in risk-adjusted in-hospital mortality compared to CABG in patients with chronic coronary syndrome and left main disease.
Synapse has enriched 10 related papers. Consider them for comparative context: